NCT02382809View on ClinicalTrials.gov

Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction

PHASE4CompletedINTERVENTIONAL

Enrollment

414

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Alveolar Osteitis

Interventions

DRUG

DC071

Mouthwash, twice daily

DRUG

Placebo

Mouthwash, twice daily

Trial Locations (18)

Unknown

Tallinn

Bordeaux

Brest

Dijon

Le Petit-Quevilly

Lyon

Metz

Pierre-Bénite

Saint-Maixent-l'École

Strasbourg

Toulouse

Daugavpils

Liepāja

Riga

Valmiera

Kaunas

Klaipėda

Vilnius

All Listed Sponsors

lead

Pierre Fabre Medicament

INDUSTRY

NCT02382809 - Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction | Biotech Hunter | Biotech Hunter